tradingkey.logo
搜索

QuidelOrtho Corp

QDEL
添加自选
18.250USD
+0.070+0.39%
收盘 07/02, 13:00美东报价延迟15分钟
1.24B总市值
亏损市盈率 TTM

QuidelOrtho Corp

18.250
+0.070+0.39%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+0.39%

5天

+32.34%

1月

+19.28%

6月

-36.59%

今年开始到现在

-36.10%

1年

-39.55%

关键数据
18.510今开
18.650最高
1.22M成交量
亏损市盈率 TTM
7.16市盈率动
--股息TTM
1.80%换手率
18.180昨收
17.830最低
16.50M成交额
亏损市盈率静
0.67市净率
0.00%股息率 TTM
-20.03%ROA
35.57552周最高
0.71量比
-2.05B净利润
68.10M总股本
-17.8511每股收益TTM
0.77Beta
-49.95%ROE
9.92052周最低
4.51%振幅
35.01%毛利率
1.24B总市值
4.38回报/风险
4.30%风险率

TradingKey QuidelOrtho Corp股票评分

单位: USD 更新时间: 2026-07-02

操作建议

QuidelOrtho Corp当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名88/204位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价21.17。中期看,股价处于上升通道。近一个月,市场表现很强,技术面和基本面综合得分较高,很强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

QuidelOrtho Corp评分

相关信息

行业排名
88 / 204
全市场排名
202 / 4565
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看好

QuidelOrtho Corp亮点

亮点风险
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
利润高增长
公司净利润处于行业前列,最新年度总收入2.73B美元
估值高估
公司最新PE估值-1.02,处于3年历史高位
机构减仓
最新机构持股88.33M股,环比减少13.83%
保罗·都铎·琼斯持仓
明星投资者保罗·都铎·琼斯持仓,最新持仓市值312.25K
活跃度降低
近期活跃度降低,过去20天平均换手率0.45

分析师目标

根据 4 位分析师
持有
评级
21.167
目标均价
+16.43%
涨幅空间

QuidelOrtho Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

QuidelOrtho Corp简介

QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
公司代码QDEL
公司QuidelOrtho Corp
CEOBlaser (Brian J)
网址https://www.quidelortho.com/

常见问题

QuidelOrtho Corp(QDEL)的当前股价是多少?

QuidelOrtho Corp(QDEL)的当前股价是 18.25。

QuidelOrtho Corp的股票代码是什么?

QuidelOrtho Corp的股票代码是QDEL。

QuidelOrtho Corp股票的52周最高点是多少?

QuidelOrtho Corp股票的52周最高点是35.58。

QuidelOrtho Corp股票的52周最低点是多少?

QuidelOrtho Corp股票的52周最低点是9.92。

QuidelOrtho Corp的市值是多少?

QuidelOrtho Corp的市值是1.24B。

现在QuidelOrtho Corp(QDEL)的股票是买入、持有还是卖出?

根据分析师评级,QuidelOrtho Corp(QDEL)的总体评级为signal_hold,目标价格为21.17。

QuidelOrtho Corp(QDEL)股票的每股收益(EPS TTM)是多少

QuidelOrtho Corp(QDEL)股票的每股收益(EPS TTM)是-16.69。